Attached files
| file | filename |
|---|---|
| EX-10.20 - EXHIBIT 10.20 - TG THERAPEUTICS, INC. | tgtx_ex1020.htm |
| EX-32.1 - EXHIBIT 32.1 - TG THERAPEUTICS, INC. | tgtx_ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - TG THERAPEUTICS, INC. | tgtx_ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - TG THERAPEUTICS, INC. | tgtx_ex311.htm |
| EX-23.1 - EXHIBIT 23.1 - TG THERAPEUTICS, INC. | tgtx_ex231.htm |
| EX-21.1 - EXHIBIT 21.1 - TG THERAPEUTICS, INC. | tgtx_ex211.htm |
| 10-K - 10-K - TG THERAPEUTICS, INC. | v031418_10K.htm |
Exhibit 32.2
STATEMENT OF CHIEF FINANCIAL OFFICER
OF
TG THERAPEUTICS, INC.
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
TG THERAPEUTICS, INC.
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the annual report of TG Therapeutics, Inc. (the
“Company”) on Form 10-K for the year ended December 31,
2017 as filed with the Securities and Exchange Commission (the
“Report”), I, Sean A. Power, Chief Financial Officer of
the Company, certify, pursuant to 18 U.S.C. §1350, as adopted
pursuant to §906 of the Sarbanes-Oxley Act of 2002, that,
based on my knowledge
1) The Report fully complies
with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and
2) The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
Date: March 15,
2018
|
|
/s/ Sean A.
Power
|
|
|
Sean A. Power
Chief Financial Officer Principal Financial and
Accounting Officer
|
|